CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (USD $)	Preferred Stock Series B	Common Stock Member	Additional Paid-in Capital	Other Comprehensive Income	Accumulated Deficit	Total
Beginning Balance, Amount at Dec. 31, 2010		$ 412,000	$ 52,726,000	$ 65,000	$ (53,132,000)	$ 71,000
Beginning Balance, Shares at Dec. 31, 2010	49,999	411,769,926
Issuance of shares for cash, Amount		2,000	98,000			100,000
Issuance of shares for cash, Shares		2,000,000
Issuance of shares related to acquisition of Senior Scientific and Scientific Nanomedicine, Amount		14,000	885,000			899,000
Issuance of shares related to acquisition of Senior Scientific and Scientific Nanomedicine, Shares		14,001,000
Issuance of shares for services, Amount		12,000	792,000			804,000
Issuance of shares for services, Shares		12,287,683
Recognition of debt discount on warrants associated with debt			75,000			75,000
Vesting of stock options			408,000			408,000
Comprehensive income				(33,000)		(33,000)
Net loss					(2,287,000)	(2,287,000)
Ending Balance, Amount at Dec. 31, 2011		440,000	54,984,000	32,000	(55,419,000)	37,000
Ending Balance, Shares at Dec. 31, 2011	49,999	440,058,609
Issuance of shares for cash, Amount		13,000	617,000			630,000
Issuance of shares for cash, Shares		6,600,000
Issuance of shares for services, Amount		6,000	289,000			295,000
Issuance of shares for services, Shares		6,283,871
Recognition of debt discount on warrants associated with debt			120,000			120,000
Vesting of stock options			141,000			141,000
Forgiveness of debt by shareholder			80,000			80,000
Comprehensive income				(10,000)		(10,000)
Net loss					(2,090,000)	(2,090,000)
Ending Balance, Amount at Dec. 31, 2012		$ 459,000	$ 56,231,000	$ 22,000	$ (57,509,000)	$ (797,000)
Ending Balance, Shares at Dec. 31, 2012	49,999	458,942,480